Skip to main content

Dexcom balance sheet

  • DXCM · Nasdaq
  • Medical devices
  • Health Care Equipment
  • S&P 500
$83.33+2.38%Close 13 Nov 2026 · Market value $30.61B

At the end of fiscal 2025 (the year to 31 Dec 2025), Dexcom reported total assets of $6.34B, $917.7M in cash and equivalents, $1.34B of total debt; shareholders' equity was $2.75B.

From Dexcom's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.

Annual

Dexcom balance sheet, annual
USDFY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$3.60M$4.89M$2.60M$8.10M$43.20M$71.80M$86.10M$94.50M$441.5M$1.14B$446.2M$817.6M$1.05B$642.3M$566.3M$606.1M$917.7M
Short-term investments—$42.22M$79.40M$40.60M$11.40M$11.80M$29.10M$29.20M$107.1M$92.70M——$1.36B$1.81B$2.16B$1.73B—
Cash and short-term investments$3.60M$47.11M$82.00M$48.70M$54.60M$83.60M$115.2M$123.7M$548.6M$1.23B$446.2M$817.6M$2.41B$2.45B$2.73B$2.34B$917.7M
Accounts receivable—————$42.40M$74.10M$101.7M$134.3M$226.7M$286.3M$428.5M$514.3M$713.3M$973.9M$1.01B$1.22B
Inventory—$8.11M$8.20M$7.40M$9.00M$16.00M$35.20M$45.40M$45.20M$70.70M$119.8M$234.7M$357.3M$306.7M$559.6M$542.6M$629.1M
Current assets—$65.36M$104.5M$77.60M$93.10M$145.9M$231.3M$280.0M$744.7M$1.70B$1.97B$3.42B$3.68B$3.67B$4.43B$4.30B$4.03B
Property, plant and equipment—$10.76M$15.00M$18.90M$20.70M$31.20M$54.70M$109.4M$145.6M$183.1M$321.3M$515.3M$801.8M$1.06B———
Goodwill——$0.00$3.20M$3.20M$3.20M$3.70M$11.30M$12.10M$18.70M$18.60M$19.30M$26.50M$25.70M$25.20M$22.80M$24.20M
Acquired intangibles——$0.00$4.20M$3.60M$2.70M$2.20M$200.0K————$31.50M$173.3M$134.5M$103.4M$70.80M
Long-term investments—————————————$19.00M$38.50M$119.3M$218.0M
Total assets—$77.16M$120.5M$106.0M$122.5M$184.6M$292.0M$402.8M$904.1M$1.92B$2.40B$4.29B$4.93B$5.39B$6.26B$6.48B$6.34B
Unearned revenue, current—$3.52M$1.60M$1.40M$700.0K$700.0K$800.0K$900.0K$3.20M$2.90M$1.70M$2.20M$2.10M$10.10M$18.40M$8.00M—
Current liabilities—$15.13M$14.70M$19.50M$32.10M$40.60M$66.90M$102.4M$138.9M$222.4M$360.2M$614.1M$720.8M$1.84B$1.56B$2.93B$2.14B
Operating lease liability——————————$86.00M$118.3M$119.1M$115.1M$101.2M$87.50M$95.00M
Finance lease liability——————————$15.00M$62.80M$60.30M$63.80M$63.30M$64.90M$60.50M
Total liabilities—$16.17M$16.00M$29.00M$38.40M$44.40M$70.80M$119.0M$484.7M$1.25B$1.51B$2.46B$2.89B$3.26B$4.20B$4.38B$3.59B
Retained earnings—−$346.4M−$391.1M−$445.6M−$475.4M−$497.8M−$555.4M−$621.0M−$671.8M−$798.9M−$695.7M−$202.1M$138.7M$479.9M$1.02B$1.60B$2.43B
Shareholders' equity−$18.40M$60.99M$104.5M$77.00M$84.10M$140.2M$221.2M$283.8M$419.4M$663.3M$882.6M$1.83B$2.04B$2.13B$2.07B$2.10B$2.75B
Total liabilities and equity—$77.16M$120.5M$106.0M$122.5M$184.6M$292.0M$402.8M$904.1M$1.92B$2.40B$4.29B$4.93B$5.39B$6.26B$6.48B$6.34B
Total debt———$7.00M$6.80M$4.60M—$0.00$327.6M$1.01B$1.15B$1.79B$2.10B$1.31B$2.54B$1.32B$1.34B
Net debt———−$41.70M−$47.80M−$79.00M—−$123.7M−$221.0M−$219.4M$699.5M$967.9M−$311.7M−$1.14B−$190.9M−$1.01B$418.2M
Net working capital—$45.34M$87.20M$50.00M$17.80M$33.50M$78.30M$83.10M$164.3M$340.1M$1.16B$1.99B$1.91B$1.19B$2.30B$763.3M$973.1M
Shares outstanding · period end—248M270M278M290M309M327M338M348M360M366M384M388M386M385M391M385M

Quarterly

Dexcom balance sheet, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Cash and equivalents$566.3M$851.2M$939.2M$621.2M$606.1M$904.9M$1.16B$1.84B$917.7M$1.12B$1.10B$961.4M
Short-term investments$2.16B$1.77B$2.03B$1.65B$1.73B$1.56B——————
Cash and short-term investments$2.73B$2.62B$2.97B$2.27B$2.34B$2.46B$1.16B$1.84B$917.7M$1.12B$1.10B$961.4M
Accounts receivable$973.9M$978.6M$945.2M$1.00B$1.01B$1.16B$1.35B$1.11B$1.22B$1.09B$1.26B$1.19B
Inventory$559.6M$589.1M$570.3M$586.3M$542.6M$538.2M$570.7M$604.1M$629.1M$693.6M$726.4M$770.7M
Current assets$4.43B$4.62B$4.85B$4.26B$4.30B$4.55B$5.03B$5.22B$4.03B$4.33B$4.09B$3.92B
Goodwill$25.20M$23.20M$23.30M$23.80M$22.80M$23.10M$24.10M$24.10M$24.20M$24.20M$24.10M$24.00M
Acquired intangibles$134.5M$123.3M$114.5M$106.2M$103.4M$95.20M$87.20M$79.00M$70.80M$62.60M$101.6M$89.40M
Long-term investments$38.50M$39.80M$43.60M$46.30M$119.3M$115.8M$115.8M$216.9M$218.0M$219.5M$209.5M$217.5M
Total assets$6.26B$6.48B$6.80B$6.35B$6.48B$6.75B$7.33B$7.50B$6.34B$6.63B$6.46B$6.24B
Unearned revenue, current$18.40M$16.40M$14.70M$13.90M$8.00M$7.80M$6.10M$2.90M————
Current liabilities$1.56B$1.59B$1.72B$1.73B$2.93B$3.04B$3.31B$3.34B$2.14B$2.22B$2.36B$2.25B
Operating lease liability$101.2M———$87.50M———$95.00M———
Finance lease liability$63.30M———$64.90M———$60.50M———
Total liabilities$4.20B$4.24B$4.36B$4.37B$4.38B$4.49B$4.75B$4.77B$3.59B$3.68B$3.83B$3.70B
Retained earnings$1.02B$1.17B$1.31B$1.45B$1.60B$1.70B$1.88B$2.17B$2.43B$2.63B$2.88B$3.16B
Shareholders' equity$2.07B$2.25B$2.43B$1.98B$2.10B$2.27B$2.57B$2.73B$2.75B$2.96B$2.62B$2.54B
Total liabilities and equity$6.26B$6.48B$6.80B$6.35B$6.48B$6.75B$7.33B$7.50B$6.34B$6.63B$6.46B$6.24B
Total debt$2.54B$2.53B$2.54B$2.53B$1.32B$1.32B$1.32B$1.31B$1.34B$1.33B$1.35B$1.34B
Net debt−$190.9M−$88.70M−$433.0M$261.8M−$1.01B−$1.14B$158.0M−$521.6M$418.2M$213.1M$241.1M$380.5M
Net working capital$2.30B$2.18B$2.19B$1.91B$763.3M$611.8M$562.5M$47.80M$973.1M$989.7M$623.9M$702.0M
Shares outstanding · period end385M396M401M391M391M392M392M390M385M386M377M373M

The main figures as JSON and plain text. See data and methodology.

DXCM in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.